Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego · 2008
[Molecular diagnosis of osteogenesis imperfecta type I].
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Galicka Anna, Bielawski Tomasz, Gindzieński Andrzej, Sredzińska Krystyna
Аннотация
UNLABELLED: Osteogenesis imperfecta (OI) is caused by mutations in collagen type I genes. In contrast to OI type II, III and IV where there are the structural mutations, in OI type I decreased production of normal collagen is due to the presence of a null allele. Because both pharmacological and gene therapy approaches depend on type of mutation and its consequences, quick and proper diagnosis is required.
AIM OF THE STUDY: Application of COL1A1 null allele detection and analysis of collagen synthesized by skin fibroblasts in OI type I diagnosis.
MATERIAL AND METHODS: Analysis was carried out in 17 patients and 20 healthy persons. Collagen was labeled with [3H]proline in skin fibroblasts and analyzed with electrophoretic method (SDS-PAGE) and by digestion with collagenase from Clostridium histolyticum. Nucleic acids were isolated from fibroblasts or peripheral blood and null allele was identified using a COL1A1 gene polymorphism.
RESULTS: In the group of 17 OI patients 11 were heterozygous for insertion of 4 bp in 3'UTR region of COL1A1. "Null allele" was identified in 7 patients with decreased collagen synthesis by about 50% and in 2 patients with decreased collagen synthesis by 80% and 15%. However, in one patient with decreased collagen synthesis by about 50%, both allele transcripts were present.
CONCLUSIONS: Application of 4 bp insertion in 3'UTR of COL1A1 gene to detect "null allele" confirmed clinical diagnosis in 9 among 17 OI patients. In 3 patients results of quantitative study of collagen and "null allele" detection were different, what indicate that for final diagnosis comprehensively studies are needed.
AIM OF THE STUDY: Application of COL1A1 null allele detection and analysis of collagen synthesized by skin fibroblasts in OI type I diagnosis.
MATERIAL AND METHODS: Analysis was carried out in 17 patients and 20 healthy persons. Collagen was labeled with [3H]proline in skin fibroblasts and analyzed with electrophoretic method (SDS-PAGE) and by digestion with collagenase from Clostridium histolyticum. Nucleic acids were isolated from fibroblasts or peripheral blood and null allele was identified using a COL1A1 gene polymorphism.
RESULTS: In the group of 17 OI patients 11 were heterozygous for insertion of 4 bp in 3'UTR region of COL1A1. "Null allele" was identified in 7 patients with decreased collagen synthesis by about 50% and in 2 patients with decreased collagen synthesis by 80% and 15%. However, in one patient with decreased collagen synthesis by about 50%, both allele transcripts were present.
CONCLUSIONS: Application of 4 bp insertion in 3'UTR of COL1A1 gene to detect "null allele" confirmed clinical diagnosis in 9 among 17 OI patients. In 3 patients results of quantitative study of collagen and "null allele" detection were different, what indicate that for final diagnosis comprehensively studies are needed.